February 28, 2018 / 7:32 AM / 10 months ago

BRIEF-Respiratorius Presents Positive Results From Clinical Studies Of VAL001

Feb 28 (Reuters) - RESPIRATORIUS AB (PUBL):

* RESPIRATORIUS PRESENTS POSITIVE RESULTS FROM CLINICAL STUDIES OF VAL001

* ‍PUBLISHED SCIENTIFIC RESULTS FROM PHASE I STUDY SHOW A POTENTIAL SYNERGISTIC EFFECT WITH RITUXIMAB AS VAL001 INCREASES LEVELS OF SURFACE PROTEIN CD20​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below